News
Edgewise Therapeutics Inc. (NASDAQ:EWTX) is one of the best up and coming stocks to invest in now. On June 26, Edgewise ...
In an opinion article, investigators argue that gene therapies may not achieve their full potential if the innate inflammation in Duchenne muscular dystrophy is not effectively managed.
Duchenne Muscular Dystrophy Market Size, Epidemiology, In-Market Drugs Sales, Pipeline Therapies, and Regional Outlook ...
The Buckinghamshire man went to see his local GP. Ryan went from blood tests to muscle biopsies to DNA tests, trying to get ...
Absent a federal committee’s recommendation, Duchenne muscular dystrophy advocates are trying to get states to adopt ...
Scientists have uncovered how a protein helps build and maintain vital brain connections, providing insights into the ...
5d
Irish Examiner on MSNCouple push for drug that slows down muscular dystrophy to be made available in IrelandThe drug Givinostat has been brought into parts of Britain. We want that too, but we need the government to pay for it,' said Una Ennis ...
Professor Hirohide Saito (Department of Life Science Frontiers at CiRA / The University of Tokyo) and Assistant Professor ...
Pat Cornell rolls through Portland, ME on his record-breaking 125,000-mile motorcycle journey-raising critical awareness for myotonic dystrophy (D ...
Sarepta Therapeutics has followed through on its promise to file for accelerated approval of its gene therapy SRP-9001 for Duchenne muscular dystrophy (DMD), as it aims for a launch in the middle ...
Amdocs Limited (NASDAQ:DOX) is one of the best up and coming stocks to invest in now. On July 1, MobiFone, which is a leading ...
ProBio opens a 128,000-sq.-ft. gene therapy facility in Hopewell, creating 110+ jobs and advancing global cell and gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results